In addition, we report that pharmacologic inhibition of menin, an essential transcription factor involved in the regulation of KMT2A-R target genes [65–67], and direct DYRK1A inhibition results in cell cycle arrest of KMT2A-R ALL. The gene discussed is MEN1; the disease is acute lymphoblastic leukemia.